Celexa and Imodium multi-symptom relief drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Celexa (citalopram hydrobromide) and Imodium multi-symptom relief (loperamide hydrochloride; simethicone). Common drug interactions include drug ineffective among females and diverticulitis among males.

The phase IV clinical study analyzes what interactions people have when they take Celexa and Imodium multi-symptom relief. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Celexa?

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.

What is Imodium multi-symptom relief?

Imodium multi-symptom relief has active ingredients of loperamide hydrochloride; simethicone. It is often used in diarrhea. eHealthMe is studying from 5,486 Imodium multi-symptom relief users. Check the latest studies of Imodium multi-symptom relief.



On Jul, 04, 2026

12 people who take Celexa and Imodium multi-symptom relief together, and have interactions are studied.

Celexa and Imodium multi-symptom relief drug interactions.

What are the common drug interactions of Celexa and Imodium Multi-Symptom Relief, by gender? *:

female:

  1. Drug ineffective
  2. Electrocardiogram qt prolonged
  3. Overdose
  4. Dehydration (dryness resulting from the removal of water)
  5. Dental caries
  6. Dizziness
  7. Dyspnoea (difficult or laboured respiration)
  8. Emotional distress
  9. Faeces discoloured
  10. Headache (pain in head)

male:

  1. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  2. Large intestine perforation (hole in large intestine)
  3. Cardiac failure congestive
  4. Cholecystitis (infection of gallbladder)
  5. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  6. Death
  7. Decreased appetite
  8. Drug exposure during pregnancy
  9. Dyspnoea (difficult or laboured respiration)
  10. Exomphalos (weakness of the baby's abdominal wall where the umbilical cord joins it)

What are the common drug interactions of Celexa and Imodium Multi-Symptom Relief, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Burkholderia cepacia complex infection (complex infection by group of bacteria burkholderia cepacia -resistant to common antibiotics)
  2. Cholecystitis (infection of gallbladder)
  3. Death
  4. Dehydration (dryness resulting from the removal of water)
  5. Dizziness
  6. Emotional distress
  7. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  8. Headache (pain in head)
  9. Liver injury
  10. Nausea (feeling of having an urge to vomit)

40-49:

n/a

50-59:

n/a

60+:

  1. Drug ineffective
  2. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  3. Large intestine perforation (hole in large intestine)
  4. Electrocardiogram qt prolonged
  5. Overdose
  6. Metastatic neoplasm (spreadable cancer tumour)
  7. Small intestinal obstruction (blockage in small intestine)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 4 people, 33.33%
  2. Pain: 2 people, 16.67%
  3. Sleep Disorder: 2 people, 16.67%
  4. Thyroid Diseases: 2 people, 16.67%
  5. Diabetes: 2 people, 16.67%
  6. Haemoglobin Decreased: 1 person, 8.33%
  7. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 1 person, 8.33%
  8. Hypersensitivity: 1 person, 8.33%
  9. High Blood Pressure: 1 person, 8.33%
  10. High Blood Cholesterol: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Celexa and Imodium multi-symptom relief?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Celexa and Imodium multi-symptom relief:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Imodium multi-symptom relief:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imodium multi-symptom relief and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide and loperamide hydrochloride; simethicone (the active ingredients of Celexa and Imodium multi-symptom relief, respectively), and Celexa and Imodium multi-symptom relief (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: